MedTrace Logo

Evaluation of the Anti-aging Efficacy of One Face Care Cosmetic Product

NCT06619457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-04-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the anti-wrinkle efficacy and effect on skin epigenetic and on mitochondrial morphology of a facial cosmetic product compared to a placebo

Conditions

  • Skin Aging

Interventions

OTHER

Mitopure (Urolithin A) Cream

cosmetic cream to be applied topically on face and forearms twice/daily using split/face design

OTHER

Placebo Cream

cosmetic cream to be applied topically on face and forearms twice/daily using split/face design

Sponsors & Collaborators

  • proDERM GmbH

    collaborator INDUSTRY

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Katrin Unbereit, PhD · SGS proderm GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-25
Primary Completion
2024-12-12
Completion
2024-12-12

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06619457 on ClinicalTrials.gov